SPY450.64+3.45 0.77%
DIA354.46+1.96 0.56%
IXIC15,129.09+107.28 0.71%

Stifel Initiates Coverage On Editas Medicine with Hold Rating, Announces Price Target of $65

Stifel analyst Dae Gon Ha initiates coverage on Editas Medicine (NASDAQ:EDIT) with a Hold rating and announces Price Target of $65.

Benzinga · 09/24/2021 05:20
Stifel analyst Dae Gon Ha initiates coverage on Editas Medicine (NASDAQ:EDIT) with a Hold rating and announces Price Target of $65.